Fagron NV ARSUF
25.80 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
27.00 Day range 27.00
23.50 52-week range 27.90
- YTD
- +9.79%
- 1 year
- +9.79%
News
seekingalpha.com Fagron NV (ARSUF) Q3 2026 Sales/Trading Call Transcript Fagron NV (ARSUF) Q3 2026 Sales/Trading Call Transcript
seekingalpha.com Fagron NV (ARSUF) Q2 2026 Earnings Call Transcript Fagron NV (ARSUF) Q2 2026 Earnings Call Transcript
globenewswire.com Fagron shareholders approve all proposed resolutions at the General Meetings Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 May 2026 – 6PM CET Fagron shareholders approve all proposed resolutions at the General Meetings Fagron, the leading global…
seekingalpha.com Fagron NV (ARSUF) Q1 2026 Sales/Trading Call Transcript Fagron NV (ARSUF) Q1 2026 Sales/Trading Call Transcript
globenewswire.com Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026 Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2026 – 7 AM CEST Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026 Fagron NV invites its…
globenewswire.com Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 9 April 2026 – 7:00 AM CET Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth Fagron, the…
globenewswire.com Fagron increases share capital through exercise subscription rights Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 31 March 2026 – 7PM CET Fagron increases share capital through exercise subscription rights Fagron announces that as a result of…
seekingalpha.com Fagron NV (ARSUF) Q4 2025 Earnings Call Transcript Fagron NV (ARSUF) Q4 2025 Earnings Call Transcript
seekingalpha.com Fagron NV (ARSUF) Q3 2025 Sales Call Transcript Fagron NV (OTCPK:ARSUF) Q3 2025 Sales Call October 9, 2025 3:30 AM EDT Company Participants Ignacio Artola Rafael Padilla - CEO & Executive Director Karin de Jong - CFO & Executive Director…
seekingalpha.com Fagron: Recent Capital Markets Day Confirms Upside Potential Fagron, a Belgian pharmaceutical compounding leader, has resolved previous market concerns and provided optimistic 2025-2030 guidance, projecting significant revenue and margin growth. The company…
seekingalpha.com Fagron: FDA Warning Letter Creates New Entry Opportunity Fagron: FDA Warning Letter Creates New Entry Opportunity
seekingalpha.com Fagron NV (ARSUF) Q2 2023 Earnings Call Transcript Fagron NV (OTC:ARSUF) Q2 2023 Earnings Conference Call August 3, 2023 3:30 AM ET Company Participants Karen Berg - Investor Relations Rafael Padilla - Chief Executive Officer Karin de Jong - Chief…
benzinga.com Stocks That Hit 52-Week Highs On Monday